(Q50738508)

English

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.

scientific article published on 21 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

anxiety disorder

1 reference

based on heuristic

inferred from title

Enric Álvarez Martínez

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jose Manuel Olivares

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Marina De Salas-Cansado

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jose L Carrasco

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

M Belén Ferro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Javier Rejas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

21 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Social Psychiatry and Psychiatric Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

985-996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Utilization of medical specialists by anxiety disorder patients

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Phenomenology and course of generalised anxiety disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Current considerations in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Cost of anxiety disorders in Europe.

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Generalized anxiety disorder: prevalence, burden, and cost to society.

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

National Institute for Clinical Excellence and its value judgments

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Novel treatment approaches for refractory anxiety disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings.

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Cost-Effectiveness Analysis of Escitalopram Compared with Paroxetine in Treatment of Generalized Anxiety Disorder in the United Kingdom

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0606-6

21 January 2018

Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generalized anxiety and depression in primary care: prevalence, recognition, and management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns and correlates of generalized anxiety disorder in community samples.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prevalence of psychopathology at a primary care center].

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[What is an efficient health technology in Spain?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A proposed guideline for economic evaluation of health technologies]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry out-patient clinics in Spain. Results of the LIGANDO study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Present orientations in the surgical treatment of gastric cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23086587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00127-012-0606-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23086587%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50738508&oldid=1511219429"